Skip to main content
Equibles
SERA logo

SERA · Sera Prognostics, Inc. · Metrics

Track SERA — free

Use SERA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SERA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.03 -0.02 (-0.98%) Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$80.87M
Shares
39.45M
Volume · Oct 28 317 Avg daily vol (3M) 23.3K

SERA metrics

85 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.05
Market cap
$80.87M

Price action

20 metrics
Price change (1W)
+1.0%
Price change (30D)
+1.5%
Price change (3M)
+1.0%
Price change (6M)
+3.5%
Price change (YTD)
-30.5%
Price change (1Y)
-45.2%
Trailing year
Price change (5Y)
-80.3%
52-week high
$3.75
52-week low
$1.59
Change from 52-week high
-45.3%
Change from 52-week low
+28.9%
Annualized volatility
70.2%
Annualized volatility (3M)
37.9%
Beta
0.8
RSI (14D)
50.7
Price vs SMA 50
-0.1%
Price vs SMA 200
-4.8%
Avg volume (3M)
23,298
Relative volume
0.6
Average dollar volume
$47,467

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
39.45M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
480.5×
reciprocal yield 0.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
1,144.0×
reciprocal yield 0.1%
P / book
1.3
reciprocal yield 74.1%
FCF yield
-35.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-41.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
-150.0%
Operating margin
-53,282.9%
Trailing 12 months
Net margin
-47,475.7%
Gross profit (TTM)
−$105,000
Operating profit (TTM)
−$37.30M
Net income (TTM)
−$33.23M
Trailing 12 months
Diluted EPS (TTM)
$-0.66
FCF margin
-40,211.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
$-0.74
EBITDA per diluted share (TTM)
$-0.73
Net income per diluted share (TTM)
$-0.66
Operating cash flow per diluted share (TTM)
$-0.55
Free cash flow per diluted share (TTM)
$-0.56
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.26
Stock compensation per diluted share (TTM)
$0.08
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+76.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$70,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.9%
Year over year · more shares
Revenue CAGR (3Y)
-32.9%
Revenue CAGR (5Y)
+26.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-56.0%
Return on assets
-38.3%
Debt / equity
0.0
Current ratio
2.0
EBITDA (TTM)
−$36.43M
Free cash flow (TTM)
−$28.15M
Quick ratio
2.0
Interest coverage
-5,328.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$46.45M
Latest balance sheet
Cash & equivalents
$4.40M
Total assets
$86.74M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$27.68M
Capital expenditures (TTM)
$466,000
R&D (TTM)
$13.02M
SG&A (TTM)
—
Stock compensation (TTM)
$3.93M
R&D / revenue
18,604.3%
Stock compensation / revenue
5,615.7%

Ownership (13F)

9 metrics
13F filers
47
13F filer change QoQ
-9
Institutional ownership
43.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-20.8%
Holder tenure
12.3
Price vs estimated holder cost
-55.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.3%

Short interest

3 metrics
Short interest
0.6%
Latest settlement · 21.5 days to cover
Days to cover
21.5d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$79,563
Insider-sentiment score
28 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1534969 CUSIP 81749D107 13F (30d) 11 filings 11 filers Visit website Investor relations